m.p. bio science limited

Live EstablishedSmallDeclining

m.p. bio science limited Company Information

Share M.P. BIO SCIENCE LIMITED

Company Number

06371250

Shareholders

koko corporation ltd

Group Structure

View All

Industry

Manufacture of other food products n.e.c.

 

Registered Address

3a/b harrison court, hilton, derby, DE65 5UR

m.p. bio science limited Estimated Valuation

£1.2m

Pomanda estimates the enterprise value of M.P. BIO SCIENCE LIMITED at £1.2m based on a Turnover of £2m and 0.57x industry multiple (adjusted for size and gross margin).

m.p. bio science limited Estimated Valuation

£660.4k

Pomanda estimates the enterprise value of M.P. BIO SCIENCE LIMITED at £660.4k based on an EBITDA of £165.2k and a 4x industry multiple (adjusted for size and gross margin).

m.p. bio science limited Estimated Valuation

£2.8m

Pomanda estimates the enterprise value of M.P. BIO SCIENCE LIMITED at £2.8m based on Net Assets of £1.5m and 1.94x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

M.p. Bio Science Limited Overview

M.p. Bio Science Limited is a live company located in derby, DE65 5UR with a Companies House number of 06371250. It operates in the manufacture of other food products n.e.c. sector, SIC Code 10890. Founded in September 2007, it's largest shareholder is koko corporation ltd with a 100% stake. M.p. Bio Science Limited is a established, small sized company, Pomanda has estimated its turnover at £2m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

M.p. Bio Science Limited Health Check

Pomanda's financial health check has awarded M.P. Bio Science Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

6 Strong

positive_score

2 Regular

positive_score

4 Weak

size

Size

annual sales of £2m, make it smaller than the average company (£24.1m)

£2m - M.p. Bio Science Limited

£24.1m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -9%, show it is growing at a slower rate (7.7%)

-9% - M.p. Bio Science Limited

7.7% - Industry AVG

production

Production

with a gross margin of 24.9%, this company has a comparable cost of product (24.9%)

24.9% - M.p. Bio Science Limited

24.9% - Industry AVG

profitability

Profitability

an operating margin of 8.1% make it more profitable than the average company (3.6%)

8.1% - M.p. Bio Science Limited

3.6% - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (112)

2 - M.p. Bio Science Limited

112 - Industry AVG

paystructure

Pay Structure

on an average salary of £39.2k, the company has an equivalent pay structure (£39.2k)

£39.2k - M.p. Bio Science Limited

£39.2k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £1m, this is more efficient (£235.4k)

£1m - M.p. Bio Science Limited

£235.4k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 12 days, this is earlier than average (48 days)

12 days - M.p. Bio Science Limited

48 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 70 days, this is slower than average (44 days)

70 days - M.p. Bio Science Limited

44 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 285 days, this is more than average (49 days)

285 days - M.p. Bio Science Limited

49 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 15 weeks, this is more cash available to meet short term requirements (7 weeks)

15 weeks - M.p. Bio Science Limited

7 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 24.7%, this is a lower level of debt than the average (56.3%)

24.7% - M.p. Bio Science Limited

56.3% - Industry AVG

M.P. BIO SCIENCE LIMITED financials

EXPORTms excel logo

M.P. Bio Science Limited's latest turnover from December 2023 is estimated at £2 million and the company has net assets of £1.5 million. According to their latest financial statements, M.P. Bio Science Limited has 2 employees and maintains cash reserves of £138.3 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover2,024,5643,331,0443,788,2032,658,1552,314,4202,534,3112,854,4132,166,7153,355,6223,819,6804,036,3833,743,8742,988,9662,555,0602,607,942
Other Income Or Grants000000000000000
Cost Of Sales1,520,9752,490,5232,798,8781,977,5361,721,4021,891,0182,127,6371,593,9612,511,9752,838,4613,033,5842,843,4672,247,2741,913,0961,935,684
Gross Profit503,589840,522989,325680,619593,018643,292726,776572,754843,647981,2191,002,799900,407741,692641,964672,259
Admin Expenses339,140699,916878,201366,424727,760672,778815,420803,947830,880968,7461,164,966589,930526,809487,966497,087
Operating Profit164,449140,606111,124314,195-134,742-29,486-88,644-231,19312,76712,473-162,167310,477214,883153,998175,172
Interest Payable2,59014,76316,4439,6253,5035,6783,8549710000000
Interest Receivable3,65518113225206741643571,1371,12151623458
Pre-Tax Profit165,515126,02594,694304,572-138,220-35,144-92,431-232,12212,83112,830-161,030311,597215,399154,232175,229
Tax-41,379-23,945-17,992-57,8690000-2,566-2,6940-74,783-56,004-43,185-49,064
Profit After Tax124,136102,08076,702246,703-138,220-35,144-92,431-232,12210,26510,136-161,030236,814159,395111,047126,165
Dividends Paid000000000000000
Retained Profit124,136102,08076,702246,703-138,220-35,144-92,431-232,12210,26510,136-161,030236,814159,395111,047126,165
Employee Costs78,361853,467943,030411,829400,010472,529468,057565,911522,709654,328647,113585,524471,541415,145483,088
Number Of Employees22327121214141918232321171517
EBITDA*165,199141,356157,949350,757-98,180-29,486-49,689-184,96412,76755,008-117,273351,876242,320187,142206,152

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets415,375398,614125,278154,479187,759212,629247,858255,339279,700280,679281,629922,915828,624745,351760,999
Intangible Assets1,5002,2503,0003,7504,5005,2506,0006,7507,5000000683219
Investments & Other0000000000000051
Debtors (Due After 1 year)000000000000000
Total Fixed Assets416,875400,864128,278158,229192,259217,879253,858262,089287,200280,679281,629922,915828,624746,034761,269
Stock & work in progress1,189,1301,138,3811,345,9701,075,806797,345706,298608,866503,585698,261789,650680,972577,074429,097351,042294,562
Trade Debtors66,754277,103248,273259,820197,936272,509473,138256,065407,651442,210500,054386,901383,481352,586373,903
Group Debtors40,13900000000000000
Misc Debtors77,75765,97549,68778,32668,83539,01233,83233,4110000000
Cash138,3189219,4458372,8313,8481,4767,79325,311467142,521312,451135,86570,49823,048
misc current assets000000000000000
total current assets1,512,0981,482,3801,653,3751,414,7891,066,9471,021,6671,117,312800,8541,131,2231,232,3271,323,5471,276,426948,443774,126691,513
total assets1,928,9731,883,2441,781,6531,573,0181,259,2061,239,5461,371,1701,062,9431,418,4231,513,0061,605,1762,199,3411,777,0671,520,1601,452,782
Bank overdraft046,03814,762161,89054,16549,634118,59131,0670000000
Bank loan000000000000000
Trade Creditors 294,713257,656408,830138,545218,934243,649225,307150,566457,977566,081676,766764,619526,628403,510423,241
Group/Directors Accounts082,15246,004177,82628,563113,937112,15789,6990000000
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities164,779154,42880,54588,166287,32619,57967,22477,3700000000
total current liabilities459,492540,274550,141566,427588,988426,799523,279348,702457,977566,081676,766764,619526,628403,510423,241
loans00250,00099,52300000000000
hp & lease commitments000000000000000
Accruals and Deferred Income000000000000000
other liabilities0000000014,08310,5544,307371,126425,046453,712479,849
provisions16,57014,19523,80326,06136,81441,12341,12347,16447,16447,43745,30523,76822,37919,31917,120
total long term liabilities16,57014,195273,803125,58436,81441,12341,12347,16461,24757,99149,612394,894447,425473,031496,969
total liabilities476,062554,469823,944692,011625,802467,922564,402395,866519,224624,072726,3781,159,513974,053876,541920,210
net assets1,452,9111,328,775957,709881,007633,404771,624806,768667,077899,199888,934878,7981,039,828803,014643,619532,572
total shareholders funds1,452,9111,328,775957,709881,007633,404771,624806,768667,077899,199888,934878,7981,039,828803,014643,619532,572
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit164,449140,606111,124314,195-134,742-29,486-88,644-231,19312,76712,473-162,167310,477214,883153,998175,172
Depreciation0046,07535,81235,812038,20545,479042,53544,89441,39927,43733,14430,980
Amortisation75075075075075007507500000000
Tax-41,379-23,945-17,992-57,8690000-2,566-2,6940-74,783-56,004-43,185-49,064
Stock50,749-207,589270,164278,46191,04797,432-89,395-194,676-91,389108,678103,898147,97778,05556,480294,562
Debtors-158,42845,118-40,18671,375-44,750-195,44999,319-118,175-34,559-57,844113,1533,42030,895-21,317373,903
Creditors37,057-151,174270,285-80,389-24,71518,342-232,670-307,411-108,104-110,685-87,853237,991123,118-19,731423,241
Accruals and Deferred Income10,35173,883-7,621-199,160267,747-47,64567,22477,3700000000
Deferred Taxes & Provisions2,375-9,608-2,258-10,753-4,3090-6,0410-2732,13221,5371,3893,0602,19917,120
Cash flow from operations281,282192,983170,385-347,25094,24639,228-231,100-102,15427,772-107,073-400,640365,076203,54491,262-71,016
Investing Activities
capital expenditure-16,761-273,336-16,874-2,532-10,94235,979-5,613-21,118-6,521-41,585596,392-135,690-110,027-17,960-792,198
Change in Investments0000000000000-5151
cash flow from investments-16,761-273,336-16,874-2,532-10,94235,979-5,613-21,118-6,521-41,585596,392-135,690-110,027-17,909-792,249
Financing Activities
Bank loans000000000000000
Group/Directors Accounts-82,15236,148-131,822149,263-85,3741,780112,15789,6990000000
Other Short Term Loans 000000000000000
Long term loans0-250,000150,47799,52300000000000
Hire Purchase and Lease Commitments000000000000000
other long term liabilities000000-14,083-14,0833,5296,247-366,819-53,920-28,666-26,137479,849
share issue0268,98609000000000000406,407
interest1,065-14,582-16,430-9,623-3,478-5,658-3,787-930643571,1371,12151623458
cash flow from financing-81,08740,5522,225240,063-88,852-3,87894,28774,6863,5936,604-365,682-52,799-28,150-25,903886,314
cash and cash equivalents
cash137,397-8,5248,608-1,994-1,0172,372-23,835-17,51824,844-142,054-169,930176,58665,36747,45023,048
overdraft-46,03831,276-147,128107,7254,531-68,957118,59131,0670000000
change in cash183,435-39,800155,736-109,719-5,54871,329-142,426-48,58524,844-142,054-169,930176,58665,36747,45023,048

m.p. bio science limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for m.p. bio science limited. Get real-time insights into m.p. bio science limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

M.p. Bio Science Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for m.p. bio science limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in DE65 area or any other competitors across 12 key performance metrics.

m.p. bio science limited Ownership

M.P. BIO SCIENCE LIMITED group structure

M.P. Bio Science Limited has no subsidiary companies.

Ultimate parent company

1 parent

M.P. BIO SCIENCE LIMITED

06371250

M.P. BIO SCIENCE LIMITED Shareholders

koko corporation ltd 100%

m.p. bio science limited directors

M.P. Bio Science Limited currently has 3 directors. The longest serving directors include Mr Ross McManus (Sep 2007) and Mrs Remila McManus (Jun 2008).

officercountryagestartendrole
Mr Ross McManus61 years Sep 2007- Director
Mrs Remila McManusEngland58 years Jun 2008- Director
Mr Andrew SouthamEngland63 years Nov 2020- Director

P&L

December 2023

turnover

2m

-39%

operating profit

164.4k

0%

gross margin

24.9%

-1.42%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

1.5m

+0.09%

total assets

1.9m

+0.02%

cash

138.3k

+149.18%

net assets

Total assets minus all liabilities

m.p. bio science limited company details

company number

06371250

Type

Private limited with Share Capital

industry

10890 - Manufacture of other food products n.e.c.

incorporation date

September 2007

age

18

incorporated

UK

ultimate parent company

accounts

Total Exemption Full

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

-

address

3a/b harrison court, hilton, derby, DE65 5UR

Bank

-

Legal Advisor

-

m.p. bio science limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to m.p. bio science limited.

m.p. bio science limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for M.P. BIO SCIENCE LIMITED. This can take several minutes, an email will notify you when this has completed.

m.p. bio science limited Companies House Filings - See Documents

datedescriptionview/download